# PPIO-009 Tumor Regression Grade and Tumor Location in Esophageal Cancer

> **NCT06453395** · — · COMPLETED · sponsor: **Daping Hospital and the Research Institute of Surgery of the Third Military Medical University** · enrollment: 248 (actual)

## Conditions studied

- Tumor Regression Grade

## Interventions

- **OTHER:** Patients were grouped according to tumor location

## Key facts

- **NCT ID:** NCT06453395
- **Lead sponsor:** Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-01
- **Primary completion:** 2024-06-04
- **Final completion:** 2024-06-04
- **Target enrollment:** 248 (ACTUAL)
- **Last updated:** 2024-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06453395

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06453395, "PPIO-009 Tumor Regression Grade and Tumor Location in Esophageal Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06453395. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*